Jagsonpal Pharmaceuticals Completes Equity Acquisition of Aequitas Healthcare
Jagsonpal Pharmaceuticals Ltd has finalized the acquisition of a significant equity stake in Aequitas Healthcare Private Limited. The company confirmed that it has successfully acquired 77.21% of the equity in Aequitas.The acquisition marks an update to Jagsonpal's investment strategy, as the finalized percentage is slightly less than the originally proposed level. Against the initially proposed acquisition target of 85% equity stake in Aequitas, Jagsonpal Pharmaceuticals Ltd has completed the purchase of a 77.21% equity share.
JAGSNPHARM Stock Price Movement
Jagsonpal Pharmaceuticals Limited shares today slipped by 4.16% to settle at ₹228.73, closing down sharply from the previous session's close. The stock traded a total of 134,755 shares during the day amid strong selling pressure.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.